Persistent pulmonary hypertension of the newborn

Saudi Medical Journal

Volumn 25, Issue 6, 2004, Pages 693-699

  Nair, P M C ^a   Bataclan, Maria Flordeliz A ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ATRACURIUM; BICARBONATE; DOBUTAMINE; DOPAMINE; FENTANYL; LUNG SURFACTANT; MAGNESIUM SULFATE; MIDAZOLAM; MORPHINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXYGEN; PANCURONIUM; PHENOBARBITAL; TOLAZOLINE; TROMETAMOL; VASODILATOR AGENT;

ALKALINIZATION; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DUCTUS ARTERIOSUS; DUODENUM PERFORATION; ECHOCARDIOGRAPHY; ENTEROPATHY; EXTRACORPOREAL OXYGENATION; GASTROINTESTINAL HEMORRHAGE; HEART FORAMEN OVALE; HEART MURMUR; HIGH FREQUENCY VENTILATION; HUMAN; HYPERVENTILATION; HYPOREFLEXIA; HYPOTENSION; HYPOXEMIA; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; NEWBORN; NEWBORN CARE; NEWBORN MORTALITY; OLIGURIA; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; REVIEW; SEDATION; SEIZURE; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN BLOOD FLOW;

ECHOCARDIOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, NEWBORN; OXYGEN INHALATION THERAPY; PERSISTENT FETAL CIRCULATION SYNDROME; VASODILATOR AGENTS;

EID: 3042857536     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983; 103: 505-514.
2. Geggel RL, Reid L. The structural basis of PPHN. Clin Perinatol 1984: 11: 525-549.
3. Whitsett JA, Pryhuber GS, Rice WR, Warner BB, Wert SE. Acute Respiratory Disorders. In: Avery GB, Fletcher MA, MacDonald MG, editors. Neonatology, Pathophysiology and Management of the Newborn, 5th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 1999. p. 497-501.
4. Rodman D. Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery. Am J Physiol 1990: 258: 207-214.
5. Abmans SH. The role of endothelial-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: 1921-1927.
6. Steinhorn RH, Millard SL, Morin FC. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment Clin Perinatol 1995; 22: 405-428.
7. Ziegler JW, Ivy D, Kinsella JP, Abman SH. The role of nitric oxide, endothelin and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol 1995; 22: 387-403.
8. Bifano EM, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988; 81: 657-661.
9. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of fetal circulation, without hyperventilation. Pediatrics 1985; 76: 488-494.
10. Varnholt V, Lasch P, Suske G, Kachel W, Brands W. High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn. Eur J Pediatr 1992; 151: 769-774.
11. Sahni R, Wung JT, James LS. Controversies in management of persistent pulmonary hypertension of the newborn. Pediatrics 1994; 94: 307-309.
12. Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hyperventilation, tolazoline and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981; 98: 603-611.
13. Welch JC, Bridson JM, Gibbs JL. Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn. Br Heart J 1995; 73: 99-100.
14. Tzong-Jin WU, Teng RU, Kuo-Inn TY. Persistent pulmonary hypertension of the newborn treated with magnesium sulphate in Premature Neonates. Pediatrics 1995: 96: 3.
15. Abu-Osba YK, Galal O, Manasra K, Rejjal A. Treatment of severe pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992: 67: 31-35.
16. Daffa SH, Milaat WA. Role of magnesium sulphate in treatment of severe pulmonary hypertension of the newborn. Saudi Med J 2002; 23: 1266-1269.
17. Daga SR, Verma B, Lotlikar RG. Magnesium sulphate for persistent pulmonary hypertension in newborns. Indian Pediatr 2000; 37: 449-450.
18. Tolsa JF, Cotting J, Sekarski N, Payot M, Micheli JL, Calame A. Magnesium sulphate as an alternate and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child 1995; 72: F184-F187.
19. Khalid MS, Bashir AI. The role of magnesium sulphate in the treatment of pulmonary hypertension of the newborn. Saud Med J 2003; 24: 801-802.
20. Parker TA, Kinsella JP, Abman SH. Response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: relationship to baseline oxygenation. J Perinatol 1998; 18: 221-225.
21. Al-Alaiyan S, Neiley E. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation. Crit Care 1999; 3: 7-10.
22. Finer NN. Inhaled nitric oxide in neonates. Arch Dis Child 1997; 77: F81-F84.
23. Kinsella JP, Abman SH. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr 1998; 157 Suppl 1: S28-S30.
24. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Chest 1998; 114: 100S.
25. Roberts JD Jr, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336: 605-610.
26. Clark RH, Kueser TJ, Walker MW. Low dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342: 469-474.
27. Kinsella JP, Abman SH. Controversies in the use of inhaled nitric oxide therapy in the newborn. Clin Perinatol 1998; 25: 203-217.
28. Konduri GG, Garcia DC, Kazzi NJ, Shankaran S. Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 1997; 3: 295-300.
29. Patole S, Lee J, Buettner P, Whitehall J. Improved oxygenation following adenosine infusion in persistent pulmonary hypertension of the newborn. Biol Neonate 1998; 74: 345-350.
30. Konduri GG, Theodorou AA, Mukhopadhyay A, Deshmukh DR. Adenosine triphosphate and adenosine increase the pulmonary blood flow to postnatal levels in fetal lambs. Pediatr Res 1992; 31: 451-457.
31. Ramgopal MV, Mustafa SJ. Effect of adenosine and its analogs on calcium influx in coronary artery. Am J Physiol 1998; 255: H1492-H1498.
32. Andrews AF, Roloff DN, Bartlett RH. Use of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Clin Perinatol 1984; 11: 729-735.
33. Donn SM. Neonatal extracorporeal membrane oxygenation. Pediatrics 1988; 82: 276-277.
34. Dworetz AR, Moya FR, Sabo B, Gladstone I, Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 1989; 84: 1-6.
35. Pfenninger J, Bachmann DC, Wagner BP. Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn [letter; comment]. Intensive Care Med 1997; 23: 233.
36. McCaffrey MJ, Bose CL, Reiter PD, Stiles AD. Effect of L-Arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 1995; 67: 240-243.
37. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002; 165: 1098-1102.
38. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002; 105: 2398-2403.
39. Lasky RE, Wiorek L, Becker TR. Hearing loss in survivors of neonatal extracorporeal membrane oxygenation and high frequency oscillatory therapy. J Am Acad Audiology 1998; 9: 47-58.